Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 1/20 | 0.33 |
| ▸ | P2RY14 | Q15391 | 2/20 | 0.33 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.33 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31744971 | 0.92 | TYMP (0.33) | TYMPP2RY14P2RY2P2RY4ALDH1A1 | |
| SCHEMBL30733459 | 0.85 | TYMP (0.33) | TYMPP2RY14P2RY2P2RY4P2RY12 | |
| SCHEMBL30733463 | 0.83 | TYMP (0.44) | TYMPP2RY14P2RY2P2RY4P2RY12 | |
| SCHEMBL30733460 | 0.83 | TYMP (0.33) | TYMPP2RY14P2RY2P2RY4P2RY12 | |
| SCHEMBL13715716 | 0.81 | TYMP (0.37) | TYMPP2RY14P2RY2P2RY4P2RY12 | |
| SCHEMBL3927922 | 0.81 | TYMP (0.37) | TYMPP2RY14P2RY2P2RY4P2RY12 | |
| SCHEMBL18034334 | 0.80 | TYMP (0.35) | TYMPP2RY14P2RY2P2RY4P2RY12 | |
| SCHEMBL2520745 | 0.80 | TYMP (0.35) | TYMPP2RY14P2RY2P2RY4P2RY12 | |
| SCHEMBL30733473 | 0.79 | TYMP (0.32) | TYMPP2RY14P2RY2P2RY4 | |
| SCHEMBL31744936 | 0.79 | TYMP (0.32) | TYMPP2RY14P2RY2P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4547852-A2 | MONOMERS AND METHODS FOR SYNTHESIS OF MODIFIED OLIGONUCLEOTIDES | Alnylam Pharmaceuticals, Inc. (US) | 2025-05-07 | — | — | EP | disclosed |
| WO-2024006953-A2 | MONOMERS AND METHODS FOR SYNTHESIS OF MODIFIED OLIGONUCLEOTIDES | ALNYLAM PHARMACEUTICALS, INC. (US) | 2024-01-04 | — | — | WO | disclosed |